Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more) Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Aethlon Medical Inc AEMD

Healthcare Medical Devices
Aethlon Medical, Inc. (Aethlon) is a medical therapeutic company focused on developing the Hemopurifier, a clinical-stage immunotherapeutic device which is designed to combat cancer and life-threatening viral infections suppression, seed the spread of metastasis and inhibit the benefit of cancer therapies. The Hemopurifier is designed to deplete the presence of circulating tumor-derived... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:AEMD)

Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices

PR Newswire February 21, 2024

Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate Update

PR Newswire February 14, 2024

Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 14, 2024

PR Newswire February 7, 2024

Aethlon Medical Announces Fiscal Second Quarter Financial Results and Provides Corporate Update

PR Newswire November 14, 2023

Aethlon Medical Announces Appointment of James B. Frakes, M.B.A. as Interim Chief Executive Officer and Guy Cipriani, M.B.A. as Chief Operating Officer

PR Newswire November 13, 2023

Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2023

PR Newswire November 6, 2023

Aethlon Receives Clearance From Drug Controller General of India For Potential Phase 1 Trial of its Hemopurifier® in Oncology

PR Newswire October 10, 2023

Aethlon Announces Reverse Stock Split

PR Newswire October 4, 2023

Aethlon Medical to Present at the H.C. Wainwright 25th Annual Global Investment Conference

PR Newswire August 30, 2023
View More News ››

Opinion & Analysis (NDAQ:AEMD)

Exosome Sciences uncovers biomarker candidate to ID Players with CTE

The Life Sciences Report May 6, 2016

Aethlon Medical CEO Jim Joyce Discusses the Forthcoming 'Concussion' Movie and CTE Research Being Conducted by Aethlon's Exosome Sciences Subsidiary

Gail Dutton December 23, 2015

Aethlon Medical's biofiltration platform tackles everything from ebola to cancer: CEO James Joyce

Gail Dutton October 30, 2015

Eight ways to leverage the small-cap biotech bull market: Ajay Tandon and Jay Albany of SeeThruEquity

Gail Dutton October 30, 2015

Cutting-edge devices and diagnostics deliver drugs and profits: Cantor Fitzgerald's Caroline Corner

George S. Mack July 31, 2015

Four small-cap medtech primed for outsize returns: Zacks' Brian Marckx

The Life Sciences Report July 15, 2015
View More Opinion ››

Bullboard Posts (NDAQ:AEMD)

Bounce Coming ?

My spider senses are tingling again.  added more in low two's  maybe another pop early in the new year? ...
mercedesman - December 23, 2021

AEMD - Tuesday Rundown, Wednesday Expectations

<< View Post To Watch Video >>
HDavis - September 21, 2021

Starting to add again.

Especially since they are now loaded up with cash (about $ 1.67 in cash, per share o/s...low float) News of a CRO on their 40 person...
mercedesman - September 14, 2021

RE:RE:RE:Reloaded

Well... I guess the market loved the two person test results from its EFS on removal of Covid-19 Exomes. Will be exiting again today...
mercedesman - June 9, 2021

RE:RE:RE:Reloaded

Thanks!
noremac50 - May 14, 2021

RE:RE:Reloaded

Hi Cam Sorry, I don't come over here often. Hemopurification is an up and coming science. Recently featured on 60 minutes. ...
mercedesman - May 7, 2021
View more Bullboard ››

LNG Energy Group Corp.

LNG Energy Group Corp.

LNG Energy Group Corp is a Canada-based company, which is focused on the acquisition and development of natural gas ...
View More »